Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-NC-BCH PET Imaging in Solid Tumors
NCT05436093Recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jun 2022
- Primary completion
- Dec 2026
- Modality
- Nanobodies (VHH)
- Countries
- 1
01
Overview
Open-label, single-arm trial in solid tumor, sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Standardized Uptake Value of 68Ga-NC-BCH at 2 years. Started Jun 2022; status: recruiting.
02
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05436093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05436093.